Case Report: Successful liver transplantation after achieving complete clinical remission of advanced HCC with Atezolizumab plus Bevacizumab combination therapy

Case Report: Successful liver transplantation after achieving complete clinical remission of advanced HCC with Atezolizumab plus Bevacizumab combination therapy

BackgroundAtezolizumab plus Bevacizumab combination therapy has recently emerged as the new standard of care for unresectable HCC. Significant tumor burden reduction can be observed under that treatment, raising the question of liver transplantation (LT). The safety of another immune checkpoint inhi...

Full description

Bibliographic Details
Main Authors: Yasmina Chouik, Domitille Erard, Hassan Demian, Thomas Schulz, Tessa Mazard, Kerstin Hartig-Lavie, Teresa Antonini, Jean-Yves Mabrut, Kayvan Mohkam, Agnès Rode, Philippe Merle
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-06-01
Series:Frontiers in Immunology
Subjects:
immunotherapy
case-report
liver transplantation
Atezolizumab
complete response
Bevacizumab
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1205997/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1205997/full

Similar Items